Lipigon press releases and news

Lipigon Pharmaceuticals enters into target validation research agreement with German antisense company Secarna Pharmaceuticals

Lipigon Pharmaceuticals (“Lipigon”) announced today that it has entered into a Target Validation Research Agreement with Munich-based antisense therapeutics company Secarna Pharmaceuticals (“Secarna”).

Read more

Lipigon has been nominated as university spin-out of the year

Lipigon is nominated as this year’s spin-out company at UmeåGalan2017.

Read more

Lipigon Pharmaceuticals announces the appointment of a new Chairman of the Board

Effective immediately Lipigon is announcing Dr. Gisela Sitbon as new Chairman of the Board.

Read more

Lipigon Pharmaceuticals joins AstraZeneca’s BioVenturHub

Starting December 2016 Lipigon joins the AZ BioVentureHub located at AstraZeneca’s site in Mölndal, Sweden.

Read more

Lipigon welcomes new investors and partners

Lipigon is happy to announce 3 new major partners investing in the company.

Read more

Lipigon CEO Stefan K. Nilsson in interview as invited speaker for BioFIT 2016

Lipigon CEO Stefan K. Nilsson is an invited speaker at BioFIT 2016 in Lille, France.

Read more